Souhaitez-vous accéder aux communiqués récents ?

Winners to be announced at upcoming World Ocean Day Event on June 8, 2024 Geneva, Switzerland – June 6, 2024: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY),...

● GABAB PAM: Selection of drug candidates under Indivior collaboration expected by end of Q2 2024. Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 6, 2024 -...

جنيف، سويسرا / الرياض، المملكة العربية السعودية - 5 يونيو 2024 - أعلنت شركة SEALSQ Corp ("SEALSQ" أو "الشركة") (NASDAQ: LAES)، وهي شركة تركز على تطوير وبيع أشباه الموصلات ومنتجات الأجهزة والبرمجيات...

Geneva, Switzerland / Riyadh, Saudi Arabia - June 5, 2024 – SEALSQ Corp ("SEALSQ" or "Company") (NASDAQ: LAES), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum...

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 5, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a...

In 2023, Burckhardt Compression surpassed again CHF 1 billion in orders and achieved new record sales and operating income.

NEW YORK and GENEVA, June 04, 2024 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN) today announced a collaboration with Mastercard, a leading global technology company in the payments industry, to...

 Announcement on the Nasdaq Tower in New York City can be viewed at https://youtu.be/28nV8L_TXaw?si=Fb1_EBN7LQcLGfFb    Livestreams of the Expo’s conferences...

Allschwil, Switzerland – June 3, 2024 Idorsia Ltd (SIX: IDIA) today announced that new data with daridorexant, Idorsia’s dual orexin receptor antagonist for the treatment of adults with insomnia,...

Allschwil, Switzerland – June 3, 2024 Idorsia Ltd (SIX: IDIA) today announced that new data with daridorexant, Idorsia’s dual orexin receptor antagonist for the treatment of adults with insomnia,...